Lv4
486 积分 2022-03-14 加入
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
3小时前
待确认
Precision Oncology: 2025 in Review
15小时前
已完结
Molecular subtypes of human skeletal muscle in cancer cachexia
2天前
已完结
Immunogenic cell death in cancer and infectious disease
9天前
已完结
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer
20天前
已完结
NK Cell-Depleting Anti-Asialo GM1 Antibody Exhibits a Lethal Off-Target Effect on Basophils In Vivo
1个月前
已完结
Anti-Asialo GM1 treatment during secondaryToxoplasma gondiiinfection is lethal and depletes T cells
1个月前
已关闭
HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer
1个月前
已完结
Metabolic hallmarks of natural killer cells in the tumor microenvironment and implications in cancer immunotherapy
2个月前
已完结
HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer
2个月前
已完结
皖公网安备34019202002308
